Compare RCKT & RIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RCKT | RIV |
|---|---|---|
| Founded | 1999 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 340.9M | 325.2M |
| IPO Year | N/A | N/A |
| Metric | RCKT | RIV |
|---|---|---|
| Price | $3.53 | $11.78 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $29.12 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 87.6K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.85% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.19 | $9.63 |
| 52 Week High | $15.00 | $12.43 |
| Indicator | RCKT | RIV |
|---|---|---|
| Relative Strength Index (RSI) | 56.59 | 55.75 |
| Support Level | $3.30 | $11.56 |
| Resistance Level | $3.45 | $11.90 |
| Average True Range (ATR) | 0.20 | 0.18 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 90.51 | 81.25 |
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
Rivernorth Opportunities Fund Inc is a diversified, closed-end management investment company. The fund's investment objective is total return consisting of capital appreciation and current income.